Yuichi Fukushima
Private Equity Investor bei Taiho Ventures LLC
Profil
Yuichi Fukushima joined Taiho ventures in July 2023.
He worked at the Taiho Pharmaceutical for 15 years and his experience includes Taiho medical affairs team for Abraxane (nab-paclitaxel), Keytruda (pembrolizumab) and Yondelis (trabectedin) for 9 years, planning and management of preclinical joint research with academia for 3 years, and corporate strategy planning for 2 years.
He received his Master of Science from Osaka University for his work on a molecular mechanism of thalamocortical axonal branching formation.
Aktive Positionen von Yuichi Fukushima
| Unternehmen | Position | Beginn |
|---|---|---|
Taiho Ventures LLC
 Taiho Ventures LLC Investment ManagersFinance Taiho Ventures LLC (Taiho Ventures) is a venture and private equity subsidiary of Taiho Pharmaceutical Co Ltd founded in 2016. The firm is headquartered in Menlo Park, California. | Private Equity Investor | 01.07.2023 |
Ausbildung von Yuichi Fukushima
| Osaka University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Taiho Ventures LLC
Taiho Ventures LLC Investment ManagersFinance Taiho Ventures LLC (Taiho Ventures) is a venture and private equity subsidiary of Taiho Pharmaceutical Co Ltd founded in 2016. The firm is headquartered in Menlo Park, California. | Finance |
